🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

5,027 results for “ERA” Clear

  1. removal of omentum

    United Therapeutics Europe Ltd

    Diabetes Mellitus Type 2

    phase 1 other completed

    1 trial

  2. riliprubart

    Vera Therapeutics

    Autoimmune haemolytic anaemia

    phase 1 small molecule active

    1 trial

  3. selinexor

    Karyopharm Therapeutics Inc

    Recurrent Melanoma

    phase 1 small molecule completed

    1 trial

  4. selinexor

    Karyopharm Therapeutics Inc

    B-cell Lymphoma

    phase 1 small molecule completed

    1 trial

  5. sevasemten

    Edgewise Therapeutics

    Healthy Subjects

    phase 1 small molecule completed

    1 trial

  6. sparsentan

    Travere Therapeutics

    Proteinuric Renal Disease

    phase 1 small molecule active

    1 trial

  7. sphingosine kinase-2 inhibitor ABC294640

    Apogee Therapeutics

    Pancreatic Cancer

    phase 1 small molecule completed

    1 trial

  8. standard chemotherapy medicine combined with Chinese herbs

    The First People's Hospital of Lianyungang

    Carcinoma, Non-Small-Cell Lung

    phase 1 small molecule active

    1 trial

  9. standard dose capecitabine

    Karyopharm Therapeutics Inc

    Rectal Neoplasms

    phase 1 small molecule active

    1 trial

  10. sulopenem etzadroxil and probenecid

    Iterum Therapeutics plc

    Pharmacokinetics After Oral Intake

    phase 1 small molecule active

    1 trial

  11. treatment A

    United Therapeutics Europe Ltd

    Dyslipidemia

    phase 1 small molecule active

    1 trial

  12. treprostinil diethanolamine

    United Therapeutics Europe Ltd

    Pulmonary Arterial Hypertension

    phase 1 small molecule completed

    2 trials

  13. zelenirstat

    United Therapeutics Europe Ltd

    Relapsed Adult AML

    phase 1 small molecule active

    1 trial

  14. zelicapavir (therapeutic dose)

    ENANTA PHARMACEUTICALS INC

    RSV Infection

    phase 1 small molecule completed

    1 trial

  15. ​​A Phase 1, Open-Label, Multiple-Part Trial to Evaluate the Drug-Drug Interaction Potential of PRAX-628 in Healthy Participants​

    Chongqing Precision Biotech Co., Ltd

    Epilepsy

    phase 1 other active

    1 trial

  16. ​​AMG 436 as monotherapy and combination therapy in participants with Microsatellite Instability-High/Mismatch Repair Deficient Solid Tumors ​

    Amgen

    microsatellite instability high/mismatch repair deficient (MSI-H/dMMR) solid tumors

    phase 1 other active

    1 trial

  17. „INSIGHT“ An explorative, open-labeled, phase I trial to evaluate feasibility and safety of eftilagimod alpha (IMP321, a LAG-3Ig fusion protein acting as LAG-3 agonist) in combination with immunotherapeutic, targeted or chemotherapeutic agents or when administered via new routes of application in advanced stage solid tumors

    The George Institute

    Histologically confirmed locally advanced or metastatic solid tumor (Strata A, B, D): Specification for Stratum C: Only patients with NSCLC adenocarcinomas, (squamous or adenosquamous not permitted) who are scheduled to receive platin + pembrolizumab + pemetrexed standard treatment (only for Stratum C) Specification for Stratum E: Including only metastatic or irresectable locally advanced urothelial carcinomas (only for Stratum E)

    phase 1 other active

    1 trial

  18. 0.1% bupivacaine

    United Therapeutics Europe Ltd

    Pregnancy

    approved small molecule active

    1 trial

  19. 0.33% ropivacaine 250ml

    Guangzhou General Hospital of Guangzhou Military Command

    Pain

    approved small molecule completed

    1 trial

  20. 100mg SPN-812

    SUPERNUS PHARMACEUTICALS, INC.

    Attention-Deficit/Hyperactivity Disorder

    approved small molecule active

    1 trial

  21. 30%Oxygen

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Atelectasis, Postoperative

    approved small molecule completed

    1 trial

  22. 37.5mg Pregabalin + 75mg Pregabalin

    The First People's Hospital of Lianyungang

    Pain, Postoperative

    approved small molecule completed

    1 trial

  23. 50,000 Units Ergocalciferol

    United Therapeutics Europe Ltd

    Pruritis

    approved small molecule completed

    1 trial

  24. 6-month clopidogrel therapy

    Hospital Authority, Hong Kong

    Coronary Artery Disease

    approved small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources